Rxsight Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Hi, everyone. I'm Steve Lichtman, medical devices analyst at Oppenheimer, and welcome to the 33rd Annual Oppenheimer Healthcare Conference. Very happy to have up with us next, RxSight. With us today from RxSight are CEO, Ron Kurtz; and CFO, Shelley Thunen.
We will have a presentation from Ron and Shelley, and then we'll have some time for Q&A. So if you do have a question, please just key it in into the chat, and I will get it over to management. But with that, I'm happy to turn the podium over to Ron. Thanks.
Thank you, Steve, and it's a pleasure to be here this morning. These are our forward-looking statements. So just to begin, RxSight is focused on the growing premium cataract surgery market, which is the most profitable segment of the highest-volume surgical procedure in ophthalmology.
Our strategy is based on delivering both better medicine for patients and better business results for doctors and practices, an approach that our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
